Icu Medical [ICUI] vs AptarGroup [ATR] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Icu Medical wins in 6 metrics, AptarGroup wins in 13 metrics, with 0 ties. AptarGroup appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricIcu MedicalAptarGroupBetter
P/E Ratio (TTM)-25.2723.01Icu Medical
Price-to-Book Ratio1.423.25Icu Medical
Debt-to-Equity Ratio66.4043.12AptarGroup
PEG Ratio0.100.95Icu Medical
EV/EBITDA12.4312.26AptarGroup
Profit Margin (TTM)-1.56%10.84%AptarGroup
Operating Margin (TTM)4.88%15.17%AptarGroup
EBITDA Margin (TTM)4.88%15.17%AptarGroup
Return on Equity-1.78%15.26%AptarGroup
Return on Assets (TTM)1.84%7.10%AptarGroup
Free Cash Flow (TTM)$113.83M$349.22MAptarGroup
Dividend YieldN/A0.90%N/A
1-Year Return-31.88%-17.04%AptarGroup
Price-to-Sales Ratio (TTM)1.272.43Icu Medical
Enterprise Value$4.12B$9.80BAptarGroup
EV/Revenue Ratio1.742.71Icu Medical
Gross Profit Margin (TTM)37.91%37.99%AptarGroup
Revenue per Share (TTM)$97$54Icu Medical
Earnings per Share (Diluted)$-1.52$5.79AptarGroup
Beta (Stock Volatility)0.830.55AptarGroup
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Icu Medical vs AptarGroup Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Icu Medical-0.57%2.74%-1.64%-9.87%-13.77%-22.73%
AptarGroup-1.01%0.70%-1.48%-17.28%-10.39%-13.58%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Icu Medical-31.88%-18.61%-36.37%17.79%227.00%333.80%
AptarGroup-17.04%41.75%14.05%89.61%186.86%433.73%

News Based Sentiment: Icu Medical vs AptarGroup

Icu Medical

News based Sentiment: MIXED

ICU Medical is presenting a mixed investment story this month. While analysts suggest significant undervaluation and insider buying indicates confidence, the company is grappling with declining sales, high debt, and a recent FDA warning. These conflicting signals create a complex picture for investors.

View Icu Medical News Sentiment Analysis

AptarGroup

News based Sentiment: MIXED

AptarGroup had a strong month financially with an earnings beat and dividend increase, but the emergence of a significant antitrust lawsuit creates substantial uncertainty and risk for investors. The mixed analyst sentiment reflects this duality, making October a pivotal month for the company's trajectory.

View AptarGroup News Sentiment Analysis

Performance & Financial Health Analysis: Icu Medical vs AptarGroup

MetricICUIATR
Market Information
Market Cap i$3.06B$8.78B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i259,010369,980
90 Day Avg. Volume i280,250422,013
Last Close$121.38$131.88
52 Week Range$107.00 - $196.26$130.27 - $178.03
% from 52W High-38.15%-25.92%
All-Time High$321.70 (Aug 06, 2018)$178.03 (Nov 11, 2024)
% from All-Time High-62.27%-25.92%
Growth Metrics
Quarterly Revenue Growth-0.08%0.06%
Quarterly Earnings Growth-0.08%0.24%
Financial Health
Profit Margin (TTM) i-0.02%0.11%
Operating Margin (TTM) i0.05%0.15%
Return on Equity (TTM) i-0.02%0.15%
Debt to Equity (MRQ) i66.4043.12
Cash & Liquidity
Book Value per Share (MRQ)$85.71$41.04
Cash per Share (MRQ)$12.15$2.58
Operating Cash Flow (TTM) i$138.83M$616.20M
Levered Free Cash Flow (TTM) i$247.93M$291.79M
Dividends
Last 12-Month Dividend Yield iN/A0.90%
Last 12-Month Dividend iN/A$1.35

Valuation & Enterprise Metrics Analysis: Icu Medical vs AptarGroup

MetricICUIATR
Price Ratios
P/E Ratio (TTM) i-25.2723.01
Forward P/E i17.8722.47
PEG Ratio i0.100.95
Price to Sales (TTM) i1.272.43
Price to Book (MRQ) i1.423.25
Market Capitalization
Market Capitalization i$3.06B$8.78B
Enterprise Value i$4.12B$9.80B
Enterprise Value Metrics
Enterprise to Revenue i1.742.71
Enterprise to EBITDA i12.4312.26
Risk & Other Metrics
Beta i0.830.55
Book Value per Share (MRQ) i$85.71$41.04

Financial Statements Comparison: Icu Medical vs AptarGroup

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ICUIATR
Revenue/Sales i$604.70M$887.31M
Cost of Goods Sold i$394.59M$550.89M
Gross Profit i$210.11M$336.41M
Research & Development i$23.29MN/A
Operating Income (EBIT) i$29.59M$115.49M
EBITDA i$82.47M$186.15M
Pre-Tax Income i$-10.91M$106.02M
Income Tax i$4.57M$27.35M
Net Income (Profit) i$-15.48M$78.66M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ICUIATR
Cash & Equivalents i$289.70M$125.84M
Total Current Assets i$1.42B$1.51B
Total Current Liabilities i$549.02M$1.21B
Long-Term Debt i$1.54B$612.02M
Total Shareholders Equity i$1.99B$2.55B
Retained Earnings i$674.68M$2.42B
Property, Plant & Equipment i$466.20M$66.57M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ICUIATR
Operating Cash Flow i$90.80M$100.50M
Capital Expenditures i$-14.62M$79,000
Free Cash Flow i$34.47M$23.41M
Debt Repayment i$-48.08M$-4.55M
Common Stock Repurchase iN/A$-80.00M

Short Interest & Institutional Ownership Analysis

MetricICUIATR
Shares Short i1.45M1.07M
Short Ratio i4.642.39
Short % of Float i0.07%0.02%
Average Daily Volume (10 Day) i259,010369,980
Average Daily Volume (90 Day) i280,250422,013
Shares Outstanding i24.52M66.50M
Float Shares i23.90M65.34M
% Held by Insiders i0.03%0.01%
% Held by Institutions i1.13%0.96%

Dividend Analysis & Yield Comparison: Icu Medical vs AptarGroup

MetricICUIATR
Last 12-Month Dividend iN/A$1.35
Last 12-Month Dividend Yield iN/A0.90%
3-Year Avg Annual Dividend iN/A$1.50
3-Year Avg Dividend Yield iN/A0.32%
3-Year Total Dividends iN/A$4.51
Ex-Dividend DateN/AFeb 05, 2025